Hello, everybody and welcome back to psychedelics today. This is Joe Moore coming at you from Breckenridge, Colorado.

Today on the show, we do something a little different.

We have a CEO, real-life CEO, JR Ron, of MindMed. I've been working to get JR on the show for ages,

finally able to pull it off, and I hope y'all like this one. We get into it about the drug war a little bit,

drug policy, and, you know and a little bit of conversation around the LSD trip stopper.

We had some disagreements, but I think it's really important that y'all hear it and hear

both sides, right?

So overall, to me, the most exciting thing about about mind med the fact that they're researching so

much lSD like i just don't understand why other groups aren't spending so much time on lSD

it's a credible compound a little bit goes a long way and yeah just really stoked that they're doing this uh really excited for jr to be

able to come on so thank you jr hope we get to do it again and um yeah this whole psychedelic industry

psychedelic scene is evolving so much quicker than any of us could ever really understand and it's um

i hear every single day about another company

in the psychedelic space that I've never heard of before. So mind med being one of the largest

backed by Kevin O'Leary of Shark Tank and others. I think most famous backers, Kevin. Yeah. So anyway,

I think that's it for the intro.

I hope you all enjoy this one.

Let me know what you think.

Psychedelics today, email at Gmail or hit us up on some of the socials out there.

Yeah, I guess that's it on the intro.

There's probably some seats left on our navigating psychedelics for clinicians and

therapist course.

...